San Diego Biotechnology Network’s Post

🔬 Join Our Upcoming Lipid Symposium! In this one-day symposium you will get an overview of the latest innovations in lipids and lipid nanoparticle (LNP) development for the delivery of mRNA-based therapies and mRNA vaccines. 💉 Symposium Highlights: ✅ Explore the growth and application of lipids for drug delivery. ✅ Learn how our novel multivariate models accelerate timelines and enhance scale-up success. ✅ Dive into the latest advances with novel lipids, including randomized PEGs (rPEGs) in LNP-based systems. You can learn about: ✅ Capabilities necessary for lipid development and manufacturing. ✅ The impact of lipid impurities on therapeutic effectiveness. ✅ Opportunities in LNP formulation with rPEGs. 🎓 Lipid Learnings Symposium 📆 November 15, 2024 📌 Cambridge, MA, USA 👉 Register now: https://lnkd.in/eeF28rWU #lipids #drugdelivery #RNAtherapies #mRNAVaccines #vaccines #mrna #pharmaceuticals #lipidnanoparticles #healthcare #workshop

Come learn more about lipids and LNP development with us in Boston next month!

🎯 A complex medicine applies novel technologies that deliver or target drugs, by modification of a pharmaceutical ingredient, formulation or using a new delivery route. Examples of successful complex medicine therapies and vaccines, include Antibody Drug Conjugates (ADCs), developed for the treatment of certain cancers, and Lipid Nanoparticles (LNPs) which delivered the COVID-19 mRNA vaccines. 🧬 We have developed a comprehensive, cutting-edge evaluation platform to support the next generation of complex medicines. Our capabilities support companies along the complex drug development pathway which include: ▶️ Assays for characterisation of complex medicines ▶️ Suite of analytical techniques to understand intracellular delivery, biodistribution and pharmacokinetics ▶️ Expertise in translational science MDC could support your #DrugDiscovery. Learn more: https://hubs.li/Q02lLSPx0 #ComplexMedicines #LifeSciences

💡 Check out the fifth episode in our bispecific antibody development series! This video dives into advanced strategies for optimizing bispecific antibody processes, including increasing cell density and achieving significant yield improvements during late-stage clinical development. 🚀 Discover how our tailored approaches, such as high-density seeding and effective material selection, enable our partners to navigate the complexities of bispecific antibody production and reach new levels of efficiency. Watch now to see how we continue to drive innovation and success in bispecific antibody development! #Biotechnology #Biopharmaceuticals #BispecificAntibodies #DrugDevelopment #CDMO #BiotechInnovation

🌟Thank you Pierre Wils for the insightful discussion on mRNA Vaccines at the #GlobalDDFSummit! Pierre Wils, Global Scientific Advisor – mRNA Center of Excellence at Sanofi, explored "mRNA Vaccines Formulation and Process Development: Challenges and Opportunities" 🚀💊

🎓Do you want to explore the latest advances in #lipid and #LNP development and manufacturing for drug delivery? Then our #workshop in Boston is perfect for you!🧑🔬 📅 When? May 13, 2024 📍Where? Boston, MA, USA Our experts Michael Parr and Dr. Lars Geiger will provide insights into the use of #lipids for #drugdelivery, and highlight the role of our novel multivariate models to speed up timelines and increase successful scale-up and transfer to the clinic. This scientific symposium will also discuss current advances in novel lipids, such as randomized PEGs (rPEGs), in LNP-based delivery systems. 🌟Key learnings for participants:🌟 💡 Introduction to capabilities needed to support lipid development and manufacturing 💡 Lipid impurities and their impact on #therapeutic effectiveness 💡 LNP #formulation opportunities with rPEGs ✍️ Reserve your seat today! https://lnkd.in/eGhFSg6Z #lipidnanoparticle #pharmaceuticals #vaccines #seminar #cdmo

Thoughts on this? >> As it deepens immunology bets, Sanofi inks small molecule pact with Belharra >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #productmarketing #healthcare

🧑🔬 A huge shoutout to our partners for their incredible support of the San Francisco Antibody Therapeutics Xchange 2024! 🌟 Your commitment to advancing antibody therapeutics is invaluable, and we’re excited to collaborate in pushing the boundaries of healthcare innovation.🧫 🧬 🥇 Lead Partner: Bio-Rad Laboratories 🤝 Our Partners: WuXi Biologics IPA (ImmunoPrecise Antibodies) Ailux Biologics ImmunXperts, a Q² Solutions Company Neochromosome, Inc. AVANTGEN Ablexis, LLC AlivaMab Biologics Now part of Catalent Biologics Single Cell Technology Inc. Antiverse Vaccinex Haven’t registered yet? There’s still time to secure your COMPLIMENTARY pass and be part of this ground-breaking event. Join us in shaping the future of medicine! https://lnkd.in/eVWkj_Pv Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. 💊 #AntibodyTherapeutics #Biopharma #HealthcareInnovation #SF2024 #LifeSciences #MedicalInnovation #BiotechInnovation #FutureOfMedicine #Pharma #SFEvents #PartneringForSuccess #TherapeuticInnovation #AntibodyEngineering #BiotechnologyLeadership #DrugDevelopment #HealthcareSolutions #ClinicalResearch #PharmaceuticalScience #PrecisionMedicine #LifeScienceCommunity #BiotechCommunity #HealthcareEcosystem #BiotechResearch #AntibodyDiscovery #NextGenTherapeutics #PharmaInnovation #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

Innovations in the pharmaceutical industry 💊 Lipid nanoparticles serve as effective carriers for mRNA vaccines by protecting the mRNA, facilitating its uptake into cells, enhancing delivery to immune cells, ensuring stability, and being safe and scalable for large-scale vaccine production. This has contributed significantly to the success of mRNA vaccines against diseases like COVID-19. The successful development and manufacturing of such biotechnology has been driven by leaders in the pharmaceutical industry such as Pfizer and Moderna. This has lead to a huge increase in the development of such therapeutics, especially in formulation for applications including vaccines and cancer treatments 🩵 During our long-term partnership, Labman has worked with Micropore Technologies Ltd and their novel AXF micro-mixing technology to build a benchtop system that automates LNP encapsulation. This system supports all levels of LNP formulations from small scale R&D development to larger scale GMP manufacturing. Find the link in the comments below to read the full story 👇 #GMPmanufacturing #bioprocessing #biotechnology #pharmaceuticalindustry

Thoughts on this? >> As it deepens immunology bets, Sanofi inks small molecule pact with Belharra >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #healthcare #productmarketing